ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

ATRA Atara Biotherapeutics Inc

0,67
0,02 (3,08%)
24 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Atara Biotherapeutics Inc ATRA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 3,08% 0,67 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,6675 0,62 0,6798 0,624 0,65
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/05/202410:25BWAtara Biotherapeutics Submits Tabelecleucel (Tab-cel®)..
09/05/202417:01BWAtara Biotherapeutics Announces First Quarter 2024 Financial..
03/05/202417:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
05/04/202417:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
28/03/202409:30BWAtara Biotherapeutics Announces Fourth Quarter and Full Year..
29/02/202411:05BWAtara Biotherapeutics Receives FDA Clearance of IND..
28/02/202418:30BWAtara Biotherapeutics to Participate in Cell Therapy Panel..
14/02/202411:00BWAtara Biotherapeutics Announces Submission of..
01/02/202404:25PRNUSAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
31/01/202420:30BWAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
08/01/202411:00BWAtara Biotherapeutics Announces $15 Million Registered..
08/01/202410:00BWAtara Biotherapeutics to Present Recent Progress and Key..
04/01/202418:01BWAtara Biotherapeutics to Present at the 42nd Annual J.P...
20/12/202318:01BWAtara Biotherapeutics Announces Closing of Expanded Global..
11/12/202314:00BWAtara Biotherapeutics Presents Positive Preclinical Data on..
01/12/202318:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
29/11/202320:05BWAtara Biotherapeutics To Present Positive New Tab-cel®..
22/11/202318:01BWAtara Biotherapeutics to Participate at the 6th Annual..
10/11/202318:01BWAtara Biotherapeutics To Participate at the Stifel..
08/11/202319:35BWAtara Biotherapeutics Announces Primary Analysis Data from..
01/11/202309:30BWAtara Biotherapeutics Announces Expanded Global Tab-cel®..
06/10/202317:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
19/09/202317:50DJNAtara Biotherapeutics to Submit New FDA Biologics License..
19/09/202317:01BWAtara Biotherapeutics Announces Plans to Submit Tab-cel® BLA..
01/09/202317:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
31/08/202317:01BWAtara Biotherapeutics to Participate in Cell Therapies in..
08/08/202317:01BWAtara Biotherapeutics Announces Second Quarter 2023..
04/08/202317:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
01/08/202317:01BWAtara Biotherapeutics to Announce Second Quarter 2023..
31/07/202317:01BWAtara Biotherapeutics to Participate in the Canaccord..
07/07/202317:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
07/06/202317:01BWAtara Biotherapeutics to Participate in the Goldman Sachs..
05/06/202310:00BWAtara Biotherapeutics Presents Updated Tab-cel® Clinical..
02/06/202317:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..

Seu Histórico Recente

Delayed Upgrade Clock